StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$6.94+0.30 (+4.52%)

Close on Nov 17, 2026Market cap $130.72MP/E 28.9Yield –

Earnings

OptimizeRx's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 4, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$21.60M
-17.2% on a year earlier
Non-GAAP net income per diluted share, Q3 FY2026
$0.20
$0.20 a year earlier
Latest guidance
Issued
Nov 13, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of OptimizeRx's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 4, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026after the close$21.60M-17.2%$0.06$0.20Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026after the close$20.50M-29.8%-$0.04$0.16Release
Q1 FY2026ended Mar 31, 2026May 12, 2026after the close$19.80M-9.6%-$0.03$0.14Release
Q4 FY2025ended Dec 31, 2025Mar 5, 2026after the close$32.20M-0.3%$0.26$0.51Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$26.10M–$0.04$0.20Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close$29.20M+55.3%$0.08$0.24Release
Q1 FY2025ended Mar 31, 2025May 12, 2025after the close$21.90M-22.9%-$0.12$0.08Release
Q4 FY2024ended Dec 31, 2024Mar 12, 2025before the open$32.30M–$0.00$0.30Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024after the close––––Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close$18.80M+36.2%-$0.22$0.02Release
Q1 FY2024ended Mar 31, 2024Apr 18, 2024after the close$28.40M+118.5%-$0.23$0.26Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

OptimizeRx's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueGAAPFY2026$87.00M – $93.00M–NewNov 13, 2026
revenueFY2026$95.00M – $100.00M$95.00M – $100.00MReaffirmedAug 12, 2026
adjusted EBITDAnon-GAAPFY2026$21.00M – $25.00M–NewNov 13, 2026
adjusted EBITDAnon-GAAPFY2026$21.00M – $25.00M$21.00M – $25.00MReaffirmedAug 12, 2026

Guidance vs results

The last range OptimizeRx gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$105.00M – $109.00M$109.40MΣ4QAbove range
Q1 FY2023Revenue$11.50M – $13.00M$13.00MWithin range

Guidance history

Every forecast OptimizeRx put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 13, 2026adjusted EBITDAFY2026$21.00M – $25.00MNew
Nov 13, 2026revenueFY2026$87.00M – $93.00MNew
Aug 12, 2026adjusted EBITDAFY2026$21.00M – $25.00MReaffirmed
Aug 12, 2026revenueFY2026$95.00M – $100.00MReaffirmed
May 12, 2026adjusted EBITDAFY2026$21.00M – $25.00MReaffirmed
May 12, 2026revenueFY2026$95.00M – $100.00MLowered
Mar 5, 2026Adjusted EBITDAFY2026$21.00M – $25.00MRaised
Mar 5, 2026revenueFY2026$109.00M – $114.00MLowered
Nov 6, 2025Adjusted EBITDAFY2025$16.00M – $19.00MNew
Nov 6, 2025Adjusted EBITDAFY2026$19.00M – $22.00MNew
Nov 6, 2025revenueFY2025$105.00M – $109.00MNew
Nov 6, 2025revenueFY2026$118.00M – $124.00MNew
Aug 7, 2025Adjusted EBITDAFY2025$14.50M – $17.50MRaised
Aug 7, 2025revenueFY2025$104.00M – $108.00MRaised
May 12, 2025Adjusted EBITDAFY2025$13.00M – $15.00MRaised
May 12, 2025revenueFY2025$101.00M – $106.00MRaised
Mar 12, 2025Adjusted EBITDAFY2025$12.00MNew
Mar 12, 2025revenueFY2025$100.00MNew
Aug 8, 2024Adjusted EBITDAFY2024$11.00MReaffirmed
Aug 8, 2024revenueFY2024$100.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases OptimizeRx filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Update
  7. Results
  8. Results
  9. Update
  10. Results
  11. Update
  12. Results
  13. Update
  14. Results
  15. Update

See a number that looks wrong?